Skip to main content
Boston Scientific10-K: Acquisition completed

Completed acquisition of Bolt Medical in Q2 2025, integrating its advanced laser platform.

What happened

The completion of the Bolt Medical acquisition brings new intravascular lithotripsy technology into the portfolio. This triggers post-merger integration activities, including systems consolidation, supply chain alignment, and sales force training, creating needs for related services and software.

Source

SEC EDGARFeb 17, 2026

Annual report (Form 10-K)

Boston Scientific 10-K for FY2025

Filing excerpt

In the second quarter of 2025, we completed our acquisition of the remaining shares of Bolt Medical, Inc. (Bolt Medical), the developer of an intravascular lithotripsy advanced laser-based platform for the treatment of coronary and peripheral artery disease.

sec.gov/Archives/edgar/data/885725/000088572526000010/bsx-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 17, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
885725
Accession number
0000885725-26-000010
Timeframe
Current year
Filing year
2026
Why it matters
Active integration needs
Signal category
Strategic

Topics and mentions

Technologies

  • intravascular lithotripsy
  • laser

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Feb 24, 2026
signal_type
sec-10k
signal_subtype
acquisitionCompleted

Use this data

Get every 10-K signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f72d6cae-04f8-4765-937b-caf37f49e0dc returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "f72d6cae-04f8-4765-937b-caf37f49e0dc",
  "signal_type": "sec-10k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-02-24T09:19:12.736+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "detail": "The completion of the Bolt Medical acquisition brings new intravascular lithotripsy technology into the portfolio. This triggers post-merger integration activities, including systems consolidation, supply chain alignment, and sales force training, creating needs for related services and software.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Completed acquisition of Bolt Medical in Q2 2025, integrating its advanced laser platform.",
    "excerpts": "In the second quarter of 2025, we completed our acquisition of the remaining shares of Bolt Medical, Inc. (Bolt Medical), the developer of an intravascular lithotripsy advanced laser-based platform for the treatment of coronary and peripheral artery disease.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000010/bsx-20251231.htm",
    "filing_date": "2026-02-17",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic",
    "technologies_mentioned": [
      "intravascular lithotripsy",
      "laser"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.